A citation-based method for searching scientific literature

Jessica P Gopie, Hans F A Vasen, Aad Tibben. Crit Rev Oncol Hematol 2012
Times Cited: 49

List of co-cited articles
279 articles co-cited >1

Times Cited
  Times     Co-cited

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011

Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.
C R M Lammens, E M A Bleiker, N K Aaronson, A Wagner, R H Sijmons, M G E M Ausems, A H J T Vriends, M W G Ruijs, T A M van Os, L Spruijt,[...]. Fam Cancer 2010

Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.
Christine Maheu, Andrea Vodermaier, Heidi Rothenmund, Steve Gallinger, Paola Ardiles, Kara Semotiuk, Spring Holter, Saumea Thayalan, Mary Jane Esplen. Fam Cancer 2010

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016

Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
Chantal R M Lammens, Neil K Aaronson, Anja Wagner, Rolf H Sijmons, Margreet G E M Ausems, Annette H J T Vriends, Mariëlle W G Ruijs, Theo A M van Os, Liesbeth Spruijt, Encarna B Gómez García,[...]. J Clin Oncol 2010

Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011

P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M G Dondon, B Bressac-de Paillerets,[...]. Br J Cancer 2000

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010

Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome.
Susan K Peterson, Rebecca D Pentz, Salma K Marani, Patricia A Ward, Amie M Blanco, Denise LaRue, Kristen Vogel, Tamara Solomon, Louise C Strong. Psychooncology 2008

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Shih-Jen Hwang, Guillermina Lozano, Christopher I Amos, Louise C Strong. Am J Hum Genet 2003

Multiple primary cancers in families with Li-Fraumeni syndrome.
M Hisada, J E Garber, C Y Fung, J F Fraumeni, F P Li. J Natl Cancer Inst 1998

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Marcia Irene Canto, Ralph H Hruban, Elliot K Fishman, Ihab R Kamel, Richard Schulick, Zhe Zhang, Mark Topazian, Naoki Takahashi, Joel Fletcher, Gloria Petersen,[...]. Gastroenterology 2012

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013

Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
Stacey L Hart, Lindsey A Torbit, Cassandra J Crangle, Mary Jane Esplen, Spring Holter, Kara Semotiuk, Ayelet Borgida, Paola Ardiles, Heidi Rothenmund, Steve Gallinger. Psychooncology 2012

Psychological distress and use of psychosocial support in familial adenomatous polyposis.
Kirsten F L Douma, Neil K Aaronson, Hans F A Vasen, Miranda A Gerritsma, Chad M Gundy, Esther P A Janssen, Annette H J T Vriends, Annemieke Cats, Senno Verhoef, Eveline M A Bleiker. Psychooncology 2010

Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.
Alexis Teplick, Megan Kowalski, Jaclyn A Biegel, Kim E Nichols. Eur J Pediatr 2011

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991

Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.
Ingrid C A W Konings, Grace N Sidharta, Femme Harinck, Cora M Aalfs, Jan-Werner Poley, Jacobien M Kieffer, Marianne A Kuenen, Ellen M A Smets, Anja Wagner, Jeanin E van Hooft,[...]. Psychooncology 2016

Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
June A Peters, Regina Kenen, Renee Bremer, Shannon Givens, Sharon A Savage, Phuong L Mai. J Genet Couns 2016

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
Kate A McBride, Mandy L Ballinger, Timothy E Schlub, Mary-Anne Young, Martin H N Tattersall, Judy Kirk, Ros Eeles, Emma Killick, Leslie G Walker, Sue Shanley,[...]. Fam Cancer 2017

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
K E Nichols, D Malkin, J E Garber, J F Fraumeni, F P Li. Cancer Epidemiol Biomarkers Prev 2001

Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.
J Hutton, L G Walker, F J Gilbert, D G Evans, R Eeles, G E Kwan-Lim, D Thompson, L J Pointon, D M Sharp, M O Leach. Br J Cancer 2011

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
Patricia Wong, Sigitas J Verselis, Judy E Garber, Katherine Schneider, Lisa DiGianni, David H Stockwell, Frederick P Li, Sapna Syngal. Gastroenterology 2006

Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
E D Lustbader, W R Williams, M L Bondy, S Strom, L C Strong. Am J Hum Genet 1992

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.
Serena Masciari, Annick D Van den Abbeele, Lisa R Diller, Iryna Rastarhuyeva, Jeffrey Yap, Katherine Schneider, Lisa Digianni, Frederick P Li, Joseph F Fraumeni, Sapna Syngal,[...]. JAMA 2008

Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.
Danielle Novetsky Friedman, Eric Lis, Charles A Sklar, Kevin C Oeffinger, Marina Reppucci, Megan Harlan Fleischut, Jasmine H Francis, Brian Marr, David H Abramson, Ira J Dunkel. Pediatr Blood Cancer 2014

Pancreatic cancer surveillance among high-risk populations: knowledge and intent.
Zoe K Lewis, Caren J Frost, Vickie L Venne. J Genet Couns 2009

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history.
Carmen Radecki Breitkopf, Pamela S Sinicrope, Kari G Rabe, Tabetha A Brockman, Christi A Patten, Robert R McWilliams, Shawna Ehlers, Gloria M Petersen. Hered Cancer Clin Pract 2012

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014

Parent decision-making around the genetic testing of children for germline TP53 mutations.
Melissa A Alderfer, Kristin Zelley, Robert B Lindell, Ana Novokmet, Phuong L Mai, Judy E Garber, Deepika Nathan, Sarah Scollon, Nicolette M Chun, Andrea F Patenaude,[...]. Cancer 2015

Li-Fraumeni syndrome: cancer risk assessment and clinical management.
Kate A McBride, Mandy L Ballinger, Emma Killick, Judy Kirk, Martin H N Tattersall, Rosalind A Eeles, David M Thomas, Gillian Mitchell. Nat Rev Clin Oncol 2014

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015

Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.
Wigdan Al-Sukhni, Ayelet Borgida, Heidi Rothenmund, Spring Holter, Kara Semotiuk, Robert Grant, Stephanie Wilson, Malcolm Moore, Steven Narod, Kartik Jhaveri,[...]. J Gastrointest Surg 2012

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983

Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.
Harriet Druker, Kristin Zelley, Rose B McGee, Sarah R Scollon, Wendy K Kohlmann, Katherine A Schneider, Kami Wolfe Schneider. Clin Cancer Res 2017

Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
Ingrid C A W Konings, Femme Harinck, Marianne A Kuenen, Grace N Sidharta, Jacobien M Kieffer, Cora M Aalfs, Jan-Werner Poley, Ellen M A Smets, Anja Wagner, Anja van Rens,[...]. Fam Cancer 2017

Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives.
Kelly A Duffy, Katheryn L Grand, Kristin Zelley, Jennifer M Kalish. J Genet Couns 2018

The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.
Jessica Ross, Jasmina Bojadzieva, Susan Peterson, Sarah Jane Noblin, Rebecca Yzquierdo, Martha Askins, Louise Strong. Genet Med 2017

Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.
Melissa A Alderfer, Robert B Lindell, Claire I Viadro, Kristin Zelley, Jessica Valdez, Belinda Mandrell, Carol A Ford, Kim E Nichols. J Genet Couns 2017

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Christian P Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose McGee,[...]. Clin Cancer Res 2017

The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing.
Veronica R Collins, Bettina Meiser, Obioha C Ukoumunne, Clara Gaff, D James St John, Jane L Halliday. Genet Med 2007

Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.
Laura Renkonen-Sinisalo, Ralf Bützow, Arto Leminen, Pentti Lehtovirta, Jukka-Pekka Mecklin, Heikki J Järvinen. Int J Cancer 2007

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Hans F A Vasen, Mohamed Abdirahman, Richard Brohet, Alexandra M J Langers, Jan H Kleibeuker, Mariette van Kouwen, Jan Jacob Koornstra, Henk Boot, Annemieke Cats, Evelien Dekker,[...]. Gastroenterology 2010

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.